日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial

在随机UNIRAD试验中,根据内分泌治疗方案的不同,辅助依维莫司治疗的获益存在差异

Saint-Ghislain, M; Chabaud, S; Dalenc, F; Allouache, D; Cameron, D; Martinez, M; Grenier, J; Barthelemy, P; Brunt, M; Kaluzinski, L; Mailliez, A; Legouffe, E; Hardy-Bessard, A-C; Giacchetti, S; Mouret-Reynier, M-A; Canon, J-L; Bliss, J; Lemonnier, J; Andre, F; Bachelot, T; Cottu, P

Causal analyses of the impact of comorbid conditions and concomitant medications on response to neoadjuvant chemotherapy in breast cancer: analysis of a multicenter prospective cohort study (CANTO)

合并症和伴随用药对乳腺癌新辅助化疗疗效影响的因果分析:一项多中心前瞻性队列研究(CANTO)的分析

Hamy, A-S; Grandal, B; Jochum, F; Dumas, É; Sella, N; Kassara, A; Barraud, S; Dubois, T; Ballesta, A; Everhard, S; Lemonnier, J; Sauzey, M; Bertaut, A; Blay, J-Y; Cottu, P; Tredan, O; Joly, F; Gougis, P; Asselain, B; Latouche, A; Vaz Luis, I; Andre, F; Reyal, F

Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial

在PARSIFAL试验中,对帕博西尼联合氟维司群或来曲唑治疗内分泌敏感、激素受体阳性/HER2阴性晚期乳腺癌患者进行了延长随访。

Llombart-Cussac, A; Pérez-García, J M; Bellet, M; Dalenc, F; Gil-Gil, M; Ruiz-Borrego, M; Gavila, J; Schmid, P; Zamora, P; Wheatley, D; Martínez-de Dueñas, E; Amillano, K; Di Cosimo, S; Anton, A; Cottu, P; Shimizu, E; Fernandez, M; Sampayo-Cordero, M; Cortés, J

Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer

早期三阴性乳腺癌新辅助治疗方案演变过程中的治疗毒性和病理反应

Arnaud, E; Vaflard, P; Escalup, L; Ramtohul, T; Meziani, D; Thibault, L; Desmaris, R-P; Feron, J-G; Pierga, J-Y; Cabel, L; Lerebours, F; Loirat, D; Cottu, P

Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial

EndoPredict 检测在接受随机、双盲 III 期 UNIRAD 试验筛查的激素受体阳性、人表皮生长因子受体 2 阴性原发性乳腺癌患者中的预后价值

Penault-Llorca, F; Dalenc, F; Chabaud, S; Cottu, P; Allouache, D; Cameron, D; Grenier, J; Venat Bouvet, L; Jegannathen, A; Campone, M; Debled, M; Hardy-Bessard, A-C; Giacchetti, S; Barthelemy, P; Kaluzinski, L; Mailliez, A; Mouret-Reynier, M-A; Legouffe, E; Cayre, A; Martinez, M; Delbaldo, C; Mollon-Grange, D; Macaskill, E J; Sephton, M; Stefani, L; Belgadi, B; Winter, M; Orfeuvre, H; Lacroix-Triki, M; Bonnefoi, H; Bliss, J; Canon, J-L; Lemonnier, J; Andre, F; Bachelot, T

Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list

促进晚期耐药癌症患者与肿瘤科医生沟通:问题提示清单的开发和可行性测试

Rault, A; Dolbeault, S; Terrasson, J; Bouleuc, C; Cottu, P; Piperno-Neumann, S; Rodrigues, M; Vaflard, P; Brédart, A

Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes

通过对患者报告结果的纵向评估,研究乳腺癌术后的性健康状况

Franzoi, M A; Aupomerol, M; Havas, J; Soldato, D; Lambertini, M; Massarotti, C; Hang, H; Pistilli, B; Fasse, L; Tredan, O; Gillanders, E; Joly, F; Cottu, P; Mouret-Reynier, M-A; Tarpin, C; Arnaud, A; Everhard, S; Martin, A-L; Di Meglio, A; Vaz-Luis, I

Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

2008-2017 年 ESME 队列中 20446 例转移性乳腺癌患者的总生存期和新疗法接受情况的演变

Grinda, T; Antoine, A; Jacot, W; Blaye, C; Cottu, P-H; Diéras, V; Dalenc, F; Gonçalves, A; Debled, M; Patsouris, A; Mouret-Reynier, M-A; Mailliez, A; Clatot, F; Levy, C; Ferrero, J-M; Desmoulins, I; Uwer, L; Petit, T; Jouannaud, C; Lacroix-Triki, M; Deluche, E; Robain, M; Courtinard, C; Bachelot, T; Brain, E; Pérol, D; Delaloge, S

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer

帕博西尼联合内分泌治疗在HR阳性、HER2阴性晚期乳腺癌中的真实世界疗效

Porte, B; Carton, M; Lerebours, F; Brain, E; Loirat, D; Haroun, L; Bellesoeur, A; Bach Hamba, S; Kirova, Y; Cottu, P

Breast referral management and outcome during COVID 19 Pandemic – A UK experience

新冠疫情期间乳腺转诊管理和结果——英国的经验

Baba, Atsunori; Tokunaga, Takuya; Sakasegawa, Koichi; Kanekura, Takuro; Tsubouchi, Hirohito; Datta, A; Myers, C; Cahir, C; Bennett, K; Shah, RN; Patel, B; Picardo, E; Bau’, MG; Mondino, A; Surace, A; Gallo, F; Anatrone, C; Danese, S; Mitideri, M; Butt, A; Hill, A; Ho, JJD; Cunningham, TA; Coughlin, CA; Lee, S; Krieger, JR; Schatz, JH; Fancellu, A; Sanna, V; Piredda, C; Ariu, L; Piana, GQ; Deiana, G; Cottu, P; Giuliani, G; Porcu, A; Wang, L; Sribaskaran, B; Ibrahim, M; Karim, M; Neal, A; Giacometti, C; Maino, M; Ambrosi, A; Zanovello, S; Beda, M; Mion, M; Mancuso, T; Duodeci, S; Cassaro, M; Noor, L; Horn, S; Shin, H; Turner, EJ